The Perfect eye drop is a nanoparticle Mist

Why? 

Because nanoparticle size eye product absorbs deeper, stays longer, and they can reach more tissues. 

Visuvet® packaging produces particles of the smallest size category.

Some examples:

A nanometer is 1 billionth of a meter. 

The ratio of a nanometer is roughly the same as the earth to a marble.

A strand of DNA is about 2 1/2 nanometers.

The thickness of a sheet of paper is about 100,000 nanometers.

The superfine mist is barely noticed by pets, no struggle with this! 

VIZOOVET® PLUS NANOPARTICLE MIST

The First and only Nanoparticle eye drop for pets.

There are 3 categories of nanoparticles.

VIZOOVET® PLUS packaging produces particles of the smallest size category.

1. Nanoparticles have the capacity to deliver ocular drugs to specific target sites and hold promise to revolutionize the therapy of many eye diseases.

2. They can improve penetration, sustained delivery, and controlled release of different drugs for ophthalmic therapeutic applications.

Nano-ophthalmology is a rapidly developing field of ophthalmic science that involves the use of nanotechnology in the diagnosis and treatment of eye disorders. It focuses on developing nanoscale devices and materials that can be used to target specific cells and tissues in the eye with high precision and efficacy. The use of nanotechnology in ophthalmology has several advantages over traditional treatment modalities. For one, nanoscale devices can penetrate deeper into the structures of the eye than traditional drugs, enabling targeted drug delivery to specific cells and tissues. This targeted approach reduces the potential for side effects and means that treatments can be more effective with smaller doses. Another advantage of nanotechnology is the potential for early diagnosis and monitoring of eye conditions. Nanoscale particles can be engineered to detect biomarkers associated with various eye diseases, enabling early detection and intervention before irreversible damage occurs. Some of the specific applications of nano-ophthalmology include the development of nanosensors for glaucoma diagnosis, nanoscale drug delivery systems for the treatment of age-related macular degeneration, and the use of nanotechnology in cataract surgery. Overall, nano-ophthalmology has the potential to revolutionize the field of ophthalmic science by providing more precise and effective treatments for a range of eye conditions. As the field continues to advance, we can expect to see more innovative approaches and devices that help improve patient outcomes and quality of life.